AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,233,265 | -53.2% | 2,688,873 | -44.8% | 1.64% | -46.0% |
| Q2 2023 | $105,130,433 | -40.6% | 4,873,919 | -19.2% | 3.04% | -41.8% |
| Q1 2023 | $177,056,455 | -21.3% | 6,034,644 | -0.9% | 5.23% | -17.2% |
| Q4 2022 | $224,963,904 | +46.0% | 6,088,333 | +11.3% | 6.32% | +41.3% |
| Q3 2022 | $154,038,000 | +125.9% | 5,472,033 | +54.6% | 4.47% | +109.3% |
| Q2 2022 | $68,188,000 | +260.0% | 3,540,408 | +140.2% | 2.14% | +463.6% |
| Q1 2022 | $18,942,000 | – | 1,474,107 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
| Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
| GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
| Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
| Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
| Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
| Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
| SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
| AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |